Skip to content
R

Rashi Sharma

Publications (4)

Microsponges Enriched Gel for Enhanced Anti-microbial Potential of Shikalkin: Development and Characterization

Rashi Sharma, Aditi Monga, Jaanvi Khanna, Manikay Mahajan, Jyoti Bhardwaj, Maninderdeep Kaur, Gurpreet Singh & Neena Bedi · Journal of Pharmaceutical Research International · 2025

Modern science has gone a long way in elucidating the beguiling properties attributed to the roots of Arnebia nobilis (Boraginaceae) containing Shikalkin (SHK). This compound holds promise as a powerful anti-microbial agent, addressing the persistent problem of microbial resistan...

Open access Research Article 10.9734/jpri/2025/v37i77712

Efficacy of Treatment in Ayurveda for the Management of Diabetic Nephropathy: A Case Study

Rashi Sharma, Punam Sawarkar, Meenu Bharti Sharma, Nitin Sharma & Gaurav Sawarkar · Journal of Pharmaceutical Research International · 2021

Diabetic Nephropathy is one of the serious clinical condition that originated as a complication of the Diabetes Mellitus. It is the main culprit for end-stage renal diseases, which ultimately may lead to life-threatening conditions. A 58 years old male patient was having diabetes...

Open access Research Article 10.9734/jpri/2021/v33i38B32094

The Physiological Aspect of Backbending Asana's

Priyanka Verma, Rashi Sharma & Biju Pegu · Journal of Pharmaceutical Research International · 2021

The Hathyogic Asanas are the preparatory limbs for spiritual awakening, but they are also an essential health science. True, practicing Asanas takes more time and work for a long-term and beneficial effect, but it is a very potent and effective therapy. The numerous organs and sy...

Open access Research Article 10.9734/jpri/2021/v33i63A35865

Topical Corticosteroids in Treatment of Atopic Dermatitis: An Overview of Their Current Status

Kusha Sharma, Abhay Tharmatt, Shivali Salooria, Rashi Sharma & Neena Bedi · Journal of Pharmaceutical Research International · 2021

Atopic dermatitis (AD) is a common skin disease characterized by epidermal changes with immune regulatory abnormalities. The pathogenesis of AD involves skin barrier defects, genetic factors and immune deregulation. The AD therapy includes skin hydration, anti-inflammatory agents...

Open access Research Article 10.9734/jpri/2020/v32i3831008